BackCoherus Biosciences Overview

Coherus Biosciences Total Liabilities

Coherus Biosciences's total liabilities is $150M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$145.85M
↓ 65.98% YoYΔ $-282.89M vs prior year quarter

Peer trimmed avg / median

Loading

Coherus Biosciences Total Liabilities History

Loading

Coherus Biosciences vs. peers: Total Liabilities Comparison

Loading

Coherus Biosciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Coherus Biosciences (CHRS) FAQ

As of the most recent data (September 2026), CHRS shows a total liabilities of $150M. That compares with $430M in the prior-year period — down 66.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CHRS's total liabilities is now $150M (was $430M) — a 66.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Coherus Biosciences is outperforming or lagging.

Tracking CHRS's total liabilities over time shows whether Coherus Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $150M That compares with $430M in the prior-year period — down 66.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Coherus Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $150M) with ownership activity and broader fundamentals.

Coherus Biosciences's total liabilities is $150M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.